<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Vasodilators: peripheral; Peripheral vascular disease; Intermittent claudication; Naftidrofuryl; Cilostazol; Raynaud's syndrome; Nifedipine; Inositol nicotinate" /><meta name="IX" content="Vasodilators: peripheral; Peripheral vascular disease; Intermittent claudication; Naftidrofuryl; Cilostazol; Raynaud's syndrome; Nifedipine; Inositol nicotinate" /><title>2.6.4 Peripheral vasodilators and related drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1393-peripheral-vasodilators-and-related-drugs.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1393-peripheral-vasodilators-and-related-drugs.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1393-peripheral-vasodilators-and-related-drugs.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1254-nitrates-calcium-channel-blockers-and-other-antianginal-drugs.htm">2.6 Nitrates, calcium-channel blockers, and other antianginal drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1390-ranolazine.htm" title="Previous: RANOLAZINE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1396-cilostazol.htm" title="Next: CILOSTAZOL">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>2.6.4 </span>Peripheral vasodilators and related drugs</h1><?highlighter on?><div id="pC" class="jN"><p>Peripheral vascular disease can be either occlusive (e.g. <em>intermittent claudication</em>) in which occlusion of the peripheral arteries is caused by atherosclerosis, or vasospastic (e.g. <em>Raynaud's syndrome</em>).</p> <p>Peripheral arterial occlusive disease is associated with an increased risk of cardiovascular events; this risk is reduced by measures such as smoking cessation (<a title="BNF:sub-section: Cigarette smoking" href="PHP3188-nicotine-dependence.htm">section 4.10.2</a>), effective control of blood pressure (<a title="section: Hypertension and heart failure" href="PHP1034-hypertension-and-heart-failure.htm">section 2.5</a>), regulating blood lipids (<a title="section: Lipid-regulating drugs" href="PHP1621-lipid-regulating-drugs.htm">section 2.12</a>), optimising glycaemic control in diabetes (<a title="section: Drugs used in diabetes" href="PHP4032-drugs-used-in-diabetes.htm">section 6.1</a>), taking aspirin in a dose of 75 mg daily (<a title="section: Antiplatelet drugs" href="PHP1519-antiplatelet-drugs.htm">section 2.9</a>), and possibly weight reduction in obesity (<a title="section: Drugs used in the treatment of obesity" href="PHP2494-drugs-used-in-the-treatment-of-obesity.htm">section 4.5</a>). Exercise training can improve symptoms of intermittent claudication; revascularisation procedures may be appropriate.</p> <div id="PHP1394" class="cI"><p class="cAE">NICE guidance</p><h3 class="cT">Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease (May 2011)</h3><p>Naftidrofuryl oxalate is an option for the treatment of intermittent claudication in patients with peripheral arterial disease in whom vasodilator therapy is considered appropriate.</p><p>Cilostazol, pentoxifylline, and inositol nicotinate are not recommended for the treatment of intermittent claudication in patients with peripheral arterial disease; patients currently receiving these treatments should have the option to continue until they and their clinician consider it appropriate to stop.</p></div> <p><strong>Naftidrofuryl</strong> can alleviate symptoms of intermittent claudication and improve pain-free walking distance in moderate disease. Patients taking naftidrofuryl should be assessed for improvement after 3–6 months.</p> <p><strong>Cilostazol</strong> is licensed for use in intermittent claudication to improve walking distance in patients without peripheral tissue necrosis who do not have pain at rest (but see NICE guidance above). Patients receiving cilostazol should be assessed for improvement after 3 months. The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="PHP60-general-guidance.htm#PHP70"><em>Scottish Medicines Consortium</em></a> has advised (October 2005) that cilostazol is not recommended for the treatment of intermittent claudication within NHS Scotland.</p> <p>Inositol nicotinate and pentoxifylline are not established as being effective for the treatment of intermittent claudication.</p> <p id="PHP1395">Management of <em>Raynaud's syndrome</em> includes avoidance of exposure to cold and stopping smoking. More severe symptoms may require vasodilator treatment, which is most often successful in primary Raynaud's syndrome. <strong>Nifedipine</strong> (<a title=" Calcium-channel blockers" href="PHP1309-calcium-channel-blockers.htm">section 2.6.2</a>) is useful for reducing the frequency and severity of vasospastic attacks. Alternatively, <strong>naftidrofuryl</strong> may produce symptomatic improvement; <strong>inositol nicotinate</strong> (a nicotinic acid derivative) may also be considered. Pentoxifylline, prazosin, and moxisylyte are not established as being effective for the treatment of Raynaud's syndrome.</p> <p>Vasodilator therapy is not established as being effective for <em>chilblains</em> (<a title=" Topical circulatory preparations" href="PHP8206-topical-circulatory-preparations.htm">section 13.13</a>).</p> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP1396-cilostazol"><a href="PHP1396-cilostazol.htm" title="CILOSTAZOL">CILOSTAZOL</a></li><li id="_PHP1398-inositol-nicotinate"><a href="PHP1398-inositol-nicotinate.htm" title="INOSITOL NICOTINATE">INOSITOL NICOTINATE</a></li><li id="_PHP1400-moxisylyte"><a href="PHP1400-moxisylyte.htm" title="MOXISYLYTE">MOXISYLYTE</a></li><li id="_PHP1402-naftidrofuryl-oxalate"><a href="PHP1402-naftidrofuryl-oxalate.htm" title="NAFTIDROFURYL OXALATE">NAFTIDROFURYL OXALATE</a></li><li id="_PHP1405-pentoxifylline"><a href="PHP1405-pentoxifylline.htm" title="PENTOXIFYLLINE">PENTOXIFYLLINE</a></li><li id="_PHP1407-other-preparations-used-in-peripheral-vascular-disease"><a href="PHP1407-other-preparations-used-in-peripheral-vascular-disease.htm" title="Other preparations used in peripheral vascular disease">Other preparations used in peripheral vascular disease</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1390-ranolazine.htm">Previous: RANOLAZINE</a> | <a class="top" href="PHP1393-peripheral-vasodilators-and-related-drugs.htm#">Top</a> | <a accesskey="]" href="PHP1396-cilostazol.htm">Next: CILOSTAZOL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>